A recent study had great results in preventing glaucoma or stopping the progress of glaucoma by supplementing the diet of mice with vitamin B3 (nicotinamide). But now the research needs to see if this also holds true for humans.
Glaucoma is a common neurodegenerative disease that results in vision loss. Two main risk factors are increasing age and high intraocular pressure (pressure in the eye). The researchers said that their next step is testing B3 in human glaucoma patients. So stay tuned...
Vitamin B3, also known as niacin, is an essential vitamin for health, but both deficiencies and too high doses have negative health effects. It is recommended that adults get between 14 mg to 18 mg of niacin per day. Since it is not stored in the body (the excess will be excreted in urine), then you need to get a continuous supply from your diet.
As seen in so many other studies of vitamins and minerals, there is no evidence of adverse effects from the consumption of naturally occurring niacin in foods, but one can get too much from supplements (along with negative health effects).
What foods are good sources of B3 (niacin)? Foods highest in B3 (niacin) are tuna, chicken, turkey, but other good sources are anchovies, salmon, sardines, red meat, peanuts, nuts, seeds, eggs, mushrooms, dairy foods. lentils, beans, potatoes, and grain products.
From Medical Xpress: Vitamin B3 prevents glaucoma in laboratory mice
In mice genetically predisposed to glaucoma, vitamin B3 added to drinking water is effective at preventing the disease, a research team led by Jackson Laboratory Professor and Howard Hughes Medical Investigator Simon W.M. John reports in the journal Science.
The vitamin administration was surprisingly effective, eliminating the vast majority of age-related molecular changes and providing a remarkably robust protection against glaucoma. It offers promise for developing inexpensive and safe treatments for glaucoma patients.
Glaucoma is one of the most common neurodegenerative diseases, affecting an estimated 80 million people worldwide. In most glaucoma patients, harmfully high pressure inside the eye or intraocular pressure leads to the progressive dysfunction and loss of retinal ganglion cells. Retinal ganglion cells are the neuronal cells that connect the eye to the brain via the optic nerve. Increasing age is a key risk factor for glaucoma, contributing to both harmful elevation of intraocular pressure and increased neuronal vulnerability to pressure-induced damage.
Conducting a variety of genomic, metabolic, neurobiological and other tests in mice susceptible to inherited glaucoma, compared to control mice, the researchers discovered that NAD, a molecule vital to energy metabolism in neurons and other cells, declines with age. The decrease in NAD levels reduces the reliability of neurons' energy metabolism, especially under stress such as increased intraocular pressure.
In essence, the treatments of vitamin B3 (nicotinamide, an amide form of vitamin B3, also called niacinamide) boosted the metabolic reliability of aging retinal ganglion cells, keeping them healthier for longer. "Because these cells are still healthy, and still metabolically robust," says JAX Postdoctoral Associate Pete Williams, first author of the study, "even when high intraocular pressure turns on, they better resist damaging processes."
The researchers also found that a single gene-therapy application of Nmnat1 (the gene for an enzyme that makes NAD from nicotinamide) prevented glaucoma from developing in this mouse model. [Original study.}